ArticleDisease markers2022

Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB.

Jia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.